Apremilast Tablets IP 10 Mg – ABRONIX 10 Tablets

ABRONIX 10 Tablets
Composition:- Apremilast 10 mg

ABRONIX 10 Tablets – Apremilast Tablets IP 10 Mg contains Apremilast, a selective phosphodiesterase-4 (PDE4) inhibitor indicated for chronic inflammatory disorders like psoriasis and psoriatic arthritis. Regulating intracellular cAMP levels helps reduce inflammatory responses, improve lesion clearance, and maintain long-term disease control with an excellent safety and tolerability profile.

Key Points of Apremilast Tablets IP 10 Mg – ABRONIX 10 Tablets

Targeted Anti-Inflammatory Mechanism – Suppresses production of pro-inflammatory cytokines (TNF-α, IL-17, IL-23) through PDE4 inhibition.
Non-Steroidal, Non-Immunosuppressive Option–Suitable for moderate to severe psoriasis and PsA without the risks associated with steroids or systemic immunosuppressants.
Excellent Safety Profile – Requires minimal routine monitoring and has a low rate of serious adverse effects, supporting long-term therapy.

Can be Prescribed by:

• Dermatologists
• Rheumatologists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only and not intended for general public promotion. This content is meant for registered healthcare professionals only.